Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a trial of oral IW-9179 in functional dyspepsia
2012-002748-25Phase 2Completed
- Sponsor
- Ironwood Pharmaceuticals
- Start
- Sep 2012
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in functional dyspepsia (FD) comparing IW-9179 once daily with Placebo once daily (2 arms). Primary endpoint: Post-meal Symptom Severity Assessment change (7 symptoms). Started Sep 2012; status: completed.
02
Drugs
recanaclotide
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on 2012-002748-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002748-25.